Alzchem Group Ag (ALZCF) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome, ladies and gentlemen, to the Q1 Earnings Call twenty twenty six of Alzchem Group Ag. I would like to welcome the company's CEO, Andreas Nedermeyer and CFO, Andreas Lusla, who will guide you through the presentation in a moment followed by a Q and A session via audio line and chat. And with that, I hand over to you, Mr. Nedermeyer. Yes. Thank you for your warm introduction. Thank you for joining us today, and welcome to our quarter one analyst call here. As always, we will go through the presentation first and then we'll be available for all the valued questions at the end. So, let's skip the disclaimer and go directly to Page five. I think, yes, you should see the presentation. Let me briefly summarize our performance in the first quarter of twenty twenty six. We have made a very solid start into the new year. Group revenue increased by approximately 3% here on a year on year basis to approximately €149,000,000 building on an already strong comparison base. So, at the same time, profitability developed significantly better than revenue. EBITDA rose by 18% to €32,000,000 and our EBITDA margin expanded to markedly 21.7%. This clearly reflects the success of our strategic focus on high margin specialty ingredients. In particular, our ingredients once again proved to be the key growth driver here. Growth was predominantly volume driven with strong demand across human nutrition, animal nutrition and defense related applications here. As a result of this strong operational performance, net income after taxes increased by more than 20%, underlining the scalability of our business model and our disciplined cost management. From a capital markets perspective, we further strengthened our equity story by increasing the free float to around 75%, improving liquidity and ...